Cytek Biosciences/$CTKB
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Cytek Biosciences
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its patented FSP technology optimizes sensitivity and accuracy through its optical and electronic designs that utilize an inventive method of light detection and distribution to a specifically selected number and type of detectors. Its FSP cell analyzers, the Cytek Aurora, Northern Lights, and Cytek Aurora Evo systems, deliver high-resolution, high-content and high-sensitivity cell analysis and address the inherent limitations of other technologies.
Ticker
$CTKB
Sector
Primary listing
Employees
702
Headquarters
Website
CTKB Metrics
BasicAdvanced
$542M
-
-$0.52
1.31
-
Price and volume
Market cap
$542M
Beta
1.31
52-week high
$6.18
52-week low
$2.37
Average daily volume
828K
Financial strength
Current ratio
5.038
Quick ratio
4.288
Long term debt to equity
4.263
Total debt to equity
6.948
Interest coverage (TTM)
-85.20%
Profitability
EBITDA (TTM)
-32.805
Gross margin (TTM)
51.84%
Net profit margin (TTM)
-33.02%
Operating margin (TTM)
-20.04%
Effective tax rate (TTM)
-122.98%
Revenue per employee (TTM)
$290,000
Management effectiveness
Return on assets (TTM)
-5.25%
Return on equity (TTM)
-18.05%
Valuation
Price to revenue (TTM)
2.675
Price to book
1.59
Price to tangible book (TTM)
1.76
Price to free cash flow (TTM)
-60.736
Free cash flow yield (TTM)
-1.65%
Free cash flow per share (TTM)
-0.069
Growth
Revenue change (TTM)
0.52%
Earnings per share change (TTM)
941.74%
3-year revenue growth (CAGR)
7.10%
3-year earnings per share growth (CAGR)
200.74%
What the Analysts think about CTKB
Analyst ratings (Buy, Hold, Sell) for Cytek Biosciences stock.
CTKB Financial Performance
Revenues and expenses
CTKB Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Cytek Biosciences stock?
Cytek Biosciences (CTKB) has a market cap of $542M as of March 09, 2026.
What is the P/E ratio for Cytek Biosciences stock?
The price to earnings (P/E) ratio for Cytek Biosciences (CTKB) stock is 0 as of March 09, 2026.
Does Cytek Biosciences stock pay dividends?
No, Cytek Biosciences (CTKB) stock does not pay dividends to its shareholders as of March 09, 2026.
When is the next Cytek Biosciences dividend payment date?
Cytek Biosciences (CTKB) stock does not pay dividends to its shareholders.
What is the beta indicator for Cytek Biosciences?
Cytek Biosciences (CTKB) has a beta rating of 1.31. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.